SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043270
Filing Date
2013-08-06
Accepted
2013-08-06 16:02:02
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v350339_10q.htm 10-Q 400176
2 EXHIBIT 31.1 v350339_ex31-1.htm EX-31.1 10943
3 EXHIBIT 31.2 v350339_ex31-2.htm EX-31.2 10792
4 EXHIBIT 32.1 v350339_ex32-1.htm EX-32.1 5827
5 EXHIBIT 32.2 v350339_ex32-2.htm EX-32.2 5216
  Complete submission text file 0001144204-13-043270.txt   4580998

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20130630.xml EX-101.INS 423765
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20130630.xsd EX-101.SCH 35215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20130630_cal.xml EX-101.CAL 24414
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20130630_def.xml EX-101.DEF 156322
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20130630_lab.xml EX-101.LAB 217573
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20130630_pre.xml EX-101.PRE 187140
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 131013459
SIC: 2836 Biological Products, (No Diagnostic Substances)